{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:58:56Z","timestamp":1793836736414,"version":"4.6.1"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Cervical screening guidelines in the US recommend that most females can exit routine screening at age 65 years following 2 recent consecutive negative cotest results (concurrent human papillomavirus and cytology tests). However, empirical data on the subsequent risks of cancer and cancer death in this subgroup of females are limited.<\/jats:p><\/jats:sec>Objective<\/jats:title>To estimate the risks of cervical cancer and cervical cancer death among females who meet the cotesting criteria to exit screening.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>In this decision analytical comparative modeling study, 4 decision analytical models from the Cancer Intervention and Surveillance Modeling Network\u2013Cervical modeling consortium that fit common US epidemiological data targets were validated against published estimates of 3- and 5-year risks of cervical intraepithelial neoplasia grade 3 (CIN3) among females meeting exit criteria at Kaiser Permanente Northern California (KPNC).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Age-conditional and cumulative risks of cervical cancer and cervical cancer death at ages 65, 70, 75, 80, and 85 years were estimated by performing a comparative modeling analysis of the 4 models to estimate the risks of cervical cancer and cervical cancer death after exiting screening.<\/jats:p><\/jats:sec>Results<\/jats:title>All models estimated a 5-year risk of CIN3 that was within the range of empirical data from KPNC. Projections of the cumulative and age-conditional risks of cervical cancer and cervical cancer death increased with time since exiting screening. The cumulative risks of cervical cancer and cervical cancer death by age 70 years were estimated to range from 0.001% to 0.003% and from 0% to 0.001%, respectively. The cumulative risks of cervical cancer and cervical cancer death by age 85 years ranged from 0.026% to 0.081% and from 0.005% to 0.038%, respectively, across models. Results were sensitive to assumptions about screening test sensitivity and incidence of high-risk human papillomavirus.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this decision analytical comparative modeling study, a low risk of cervical cancer and cervical cancer death was estimated among females who fulfilled the US criteria to exit screening with cotesting; however, the risks increased with age and\/or time since screening exit. The findings suggest that future guidelines should consider acceptable risk levels when defining screening modality and exit age requirements.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.0479","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:00:47Z","timestamp":1741791647000},"page":"e250479","source":"Crossref","is-referenced-by-count":11,"title":["Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening"],"prefix":"10.1001","volume":"8","author":[{"given":"Shalini L.","family":"Kulasingam","sequence":"first","affiliation":[{"name":"Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge M. C. M.","family":"de Kok","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik E. L.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Caroline","family":"Regan","sequence":"additional","affiliation":[{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Killen","sequence":"additional","affiliation":[{"name":"The Daffodil Centre, University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sy","sequence":"additional","affiliation":[{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[{"name":"The Daffodil Centre, University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Smith","sequence":"additional","affiliation":[{"name":"The Daffodil Centre, University of Sydney, a joint venture with Cancer Council New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G.","family":"Campos","sequence":"additional","affiliation":[{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"3","key":"zoi250041r2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"zoi250041r3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"zoi250041r4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/LGT.0b013e3182616241","article-title":"Screening for cervical cancer: a modeling study for the US Preventive Services Task Force.","volume":"17","author":"Kulasingam","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"zoi250041r5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US Preventive Services Task Force.","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"zoi250041r6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ijc.32268","article-title":"Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.","volume":"146","author":"Landy","year":"2020","journal-title":"Int J Cancer"},{"issue":"9","key":"zoi250041r7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/jnci\/djz227","article-title":"Estimating the natural history of cervical carcinogenesis using simulation models: a CISNET comparative analysis.","volume":"112","author":"Burger","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi250041r8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0272989X20924007","article-title":"The impact of different screening model structures on cervical cancer incidence and mortality predictions: the Maximum Clinical Incidence Reduction (MCLIR) methodology.","volume":"40","author":"de Kok","year":"2020","journal-title":"Med Decis Making"},{"issue":"3","key":"zoi250041r11","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ygyno.2020.05.030","article-title":"Historical and projected hysterectomy rates in the USA: implications for future observed cervical cancer rates and evaluating prevention interventions.","volume":"158","author":"Simms","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"2","key":"zoi250041r13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"12","key":"zoi250041r14","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/ijc.29337","article-title":"Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.","volume":"136","author":"Cuzick","year":"2015","journal-title":"Int J Cancer"},{"issue":"3","key":"zoi250041r15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ygyno.2013.12.037","article-title":"Cervical excisional treatment of young women: a population-based study.","volume":"132","author":"Kinney","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"zoi250041r16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: updated reporting guidance for health economic evaluations.","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"zoi250041r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2019.100184","article-title":"HPV-FRAME: a consensus statement and quality framework for modelled evaluations of HPV-related cancer control.","volume":"8","author":"Canfell","year":"2019","journal-title":"Papillomavirus Res"},{"issue":"12","key":"zoi250041r18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S1470-2045(18)30536-9","article-title":"Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.","volume":"19","author":"Malag\u00f3n","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"zoi250041r19","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S1470-2045(17)30700-3","article-title":"Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis.","volume":"18","author":"Arbyn","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"zoi250041r20","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/infdis\/jiaa557","article-title":"Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior.","volume":"223","author":"Paul","year":"2021","journal-title":"J Infect Dis"},{"issue":"5","key":"zoi250041r21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/infdis\/jix333","article-title":"Modeling of US human papillomavirus (HPV) seroprevalence by age and sexual behavior indicates an increasing trend of HPV infection following the sexual revolution.","volume":"216","author":"Ryser","year":"2017","journal-title":"J Infect Dis"},{"issue":"1","key":"zoi250041r22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-1609","article-title":"Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study.","volume":"168","author":"Castle","year":"2018","journal-title":"Ann Intern Med"},{"key":"zoi250041r23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ypmed.2018.07.005","article-title":"How confident can we be in the current guidelines for exiting cervical screening?","volume":"114","author":"Gravitt","year":"2018","journal-title":"Prev Med"},{"issue":"1","key":"zoi250041r24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ygyno.2021.04.027","article-title":"It\u2019s time to re-evaluate cervical cancer screening after age 65.","volume":"162","author":"Dilley","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"zoi250041r25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ygyno.2021.05.035","article-title":"Eligibility for cervical cancer screening exit: comparison of a national and safety net cohort.","volume":"162","author":"Mills","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"zoi250041r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001585","article-title":"Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.","volume":"11","author":"Casta\u00f1\u00f3n","year":"2014","journal-title":"PLoS Med"},{"key":"zoi250041r1","author":"Moyer","year":"2012"},{"key":"zoi250041r9","unstructured":"SEER*Stat Database: Survival- Aggregated With State, Total US (1969-2015), Katrina\/Rita Population Adjustment, National Cancer Institute, DCCPS, Surveillance Research Program, released December 2017. Underlying mortality data provided by NCHS. Accessed February 15, 2018. https:\/\/www.cdc.gov\/nchs"},{"key":"zoi250041r10","unstructured":"National Center for Health Statistics, Centers for Disease Control and Prevention. 2009 National Hospital Discharge Survey. Accessed August 7, 2017. https:\/\/www.cdc.gov\/nchs\/nhds\/index.htm"},{"key":"zoi250041r12","unstructured":"University of California, Berkeley. United States mortality database. Accessed Augst 2, 2016. https:\/\/usa.mortality.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2831322\/kulasingam_2025_oi_250041_1741195261.03163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:00:51Z","timestamp":1741791651000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2831322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.0479","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}